Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The biofilm formation pathway refers to the complex, multi-step process by which microorganisms transition from free-living states to organized, surface-attached communities encased in a self-produced extracellular matrix. This pathway involves reversible attachment, irreversible attachment, EPS production, maturation, and dispersal, regulated by environmental cues and intercellular signaling. Key molecular components include EPS (polysaccharides, proteins, eDNA, lipids), signaling molecules (quorum sensing molecules, c-di-GMP), and regulatory proteins/genes. Biofilms confer increased resistance to antibiotics, host immune defenses, and environmental stresses, playing major roles in chronic infections.
Various mechanisms targeting different stages of biofilm formation (e.g., inhibition of EPS production, disruption of quorum sensing, interference with adhesion)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biofilm Formation Pathway.